Fig. 5
From: In vitro effects of 0 to 120 Grays of irradiation on bone viability and release of growth factors
Elisa quantification for growth factors including (a) Receptor activator of nuclear factor kappa-B ligand (RANKL) and (b) interleukin 1-beta (IL1B). a Following irradiation at 4 h, a 2 fold decrease in RANKL could be observed for control samples when compared to all irradiated doses. b No changes in IL1B could be observed at all time points following irradiation. (# denotes significantly lower than all other treatment modalities p < 0.01)